Bearish flow noted in GSK (GSK) Pharma with 5,611 puts trading, or 3x expected. Most active are Mar-25 36.5 puts and 3/14 weekly 39.5 calls, with total volume in those strikes near 6,100 contracts.

GSK Stock Performance GSK opened at $40.08 on Friday. The firm has a market cap of $83.07 billion, a P/E ratio of 25.21, a price-to-earnings-growth ratio of 1.12 and a beta of 0.58. GSK plc has a ...

NEW YORK, NY / ACCESS Newswire / March 10, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws ...

MANILA, Philippines — Netizens did not hold back when the Manila International Airport Authority (MIAA) unveiled its new logo to mark its 43rd anniversary on Friday. “Looks like a school ...

Additionally, GSK’s new 5-in-1 meningitis vaccine, Penmenvy, received approval from the US FDA, offering protection against five common serogroups of Neisseria meningitidis for individuals aged ...

The company's leadership team will continue to drive its mission forward with this new appointment. For comprehensive analysis and additional insights, including 8 more ProTips and detailed financial ...

GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine sales falling, some market participants say it may draw in activist ...

NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc ("GSK" or the "Company") (NYSE: GSK). Such investors are advised to ...

GSK investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: According to the filed complaint, defendants ...

(Bloomberg) -- GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine sales falling, some market participants say it may draw in ...